Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 30,740 | N/A | N/A |
| TOTAL | $33,431 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 3,168 | N/A | N/A |
| Other Non-Current Assets | 84 | 0 | 0 |
| TOTAL | $3,252 | $N/A | $N/A |
| Total Assets | $36,683 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,713 | 0 | 0 |
| Accrued Expenses | 603 | N/A | N/A |
| Other current liabilities | 1,165 | N/A | N/A |
| TOTAL | $3,481 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 528 | 0 | 0 |
| TOTAL | $528 | $N/A | $N/A |
| Total Liabilities | $4,009 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 170 | N/A | N/A |
| Retained earnings | -16,860 | N/A | N/A |
| Other shareholders' equity | 48,308 | 0 | 0 |
| TOTAL | $32,674 | $N/A | $N/A |
| Total Liabilities And Equity | $36,683 | $0 | $0 |